Assume that Genentech's projected free cash flow for next year is FCF, - $10,000,000, and FCF is expected to grow at a constant rate of 5.5%. The company's weighted average cost of capitalis 9.5% and it has no debtor preferred stock. Using the corporate valuation model, Genentech has 20 million shares outstanding, determine the stock's value per share. Hint: First find the total market value for Genentech using the corporate valuation model $13.25 $12.50 514.75 $16.00